丹酚酸B介导AMPK活化加剧氧化应激诱导的甲状腺癌细胞凋亡和自噬
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

湖北省武汉市科技项目


Salvianolic acid Bmediated AMPK activation exacerbates oxidative stress induced apoptosis and autophagy in thyroid cancer cells
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    【摘要】 目的 探讨丹酚酸B对氧化应激诱导的甲状腺癌细胞凋亡和自噬的影响。 方法 选择不同浓度的丹酚酸B处理甲状腺癌TPC-1和甲状腺滤泡上皮细胞Nthy-ori 3-1细胞,24 h后CCK8检测细胞存活率;选择无显著毒性的剂量 (2.5、5、10 μg/mL) 进行后续实验,流式细胞术检测细胞内活性氧(ROS)水平和细胞凋亡;蛋白印迹法检测细胞内和线粒体内细胞色素C以及凋亡、自噬相关蛋白的表达水平;免疫荧光检测LC3的水平;此外,在细胞中加入腺苷酸活化蛋白激酶(AMPK)抑制剂Compound C (50 nM) 后,将细胞随机分为对照组、丹酚酸B 10 μg/mL组、Compound C组、Compound C+丹酚酸B 10μg/mL组,〖JP2〗流式细胞术检测细胞内ROS水平和细胞凋亡;蛋白印迹法检测AMPK相关蛋白和自噬相关蛋白的表达。结果 TPC-1 和Nthy-ori 3-1细胞的存活率以丹酚酸B浓度依赖的方式降低,丹酚酸B浓度超过20 μg/mL时,TPC-1细胞的存活率显著降低(P<0.05);当丹酚酸B浓度超过40 μg/mL时,Nthy-ori 3-1细胞的存活率显著降低(P<0.05)。与对照组相比,经5、10 μg/mL丹酚酸B预处理后,TPC-1细胞内的ROS水平、凋亡率、Bax、Cleaved caspase 3、Beclin1和细胞质中Cyto C的蛋白表达水平、LC3的水平、AMPK磷酸化水平、LC3II/LC3-I 的比值均显著升高(P<0.05);Bcl-2、P62和线粒体中Cyto-C的蛋白表达水平均显著降低(P<0.05)。与对照组相比,丹酚酸B 10 μg/mL组AMPK磷酸化水平、LC3II/LC3I比值、ROS水平、细胞凋亡率均显著升高(P<0.05);Compound C组AMPK磷酸化水平,LC3-II/LC3-I比值、ROS水平、细胞凋亡率均显著降低(P<0.05)。与Compound C组比较,Compound C+丹酚酸B 10 μg/mL组AMPK磷酸化水平、LC3-II/LC3-I 的比值、ROS水平、细胞凋亡率均显著升高(P<0.05)。结论 5、 10 μg/mL的丹酚酸B可通过介导的AMPK活化加剧氧化应激诱导的甲状腺癌细胞的凋亡和自噬,以10 μg/mL的丹酚酸B效果最佳。

    Abstract:

    【Abstract】 Objective To investigate the effects of salvianolic acid B on oxidative stressinduced apoptosis and autophagy of thyroid cancer cells. Methods Different doses of salvianolic acid B were used to treat TPC-1 and thyroid follicular epithelial Nthy-ori 3-1 cells of thyroid cancer. Cell viability was detected by CCK8 after 24 hours. Doses with no significant toxicity (2.5, 5, 10 μg/mL) were selected for followup in experiments. The flow cytometry was used to detect intracellular ROS levels and apoptosis. Western blot was used to detect intracellular and mitochondrial cytochrome C and expression levels of apoptosis and autophagyrelated proteins. The immunofluorescence was used to detect LC3 levels. In addition, after adding the compound AMPK inhibitor compound C (50 nM) to the cells, the cells were randomly divided into control group, salvianolic acid B 10 μg /mL group, compound C group, compound C+salvianolic acid B 10μg/mL In the ml group. The intracellular ROS level and apoptosis were detected by flow cytometry. The expression of AMPKrelated proteins and autophagyrelated proteins were detected by Western blot. Results The survival rate of TPC-1 and Nthy-ori 3-1 cells was reduced in a salvianolic acid Bdependent manner. When salvianolic acid B concentration exceeded 20 μg/mL, the survival rate of TPC-1 cells was significantly reduced (P<0.05). When the salvianolic acid B concentration exceeded 40 μg/mL, the survival rate of Nthy-ori 3-1 cells was significantly reduced (P<0.05). Compared with the control group, ROS level, apoptosis rate, Bax, Cleaved caspase 3, Beclin1 and Cyto C protein expression level, LC3 level, AMPK phosphorylation level and LC3-II/LC3-I ratio in TPC-1 cells were significantly increased after 5 and 10 μg/mL saldanolic acid B pretreatment (P<0.05). Protein expression levels of Bcl-2, P62 and Cyto C in mitochondria were significantly decreased (P<0.05). Compared with the control group, the phosphorylation level of AMPK, the ratio of LC3-II/LC3-I, the ROS level and the apoptosis rate were significantly increased in salanolic acid B 10 μg/mL group (P<0.05). The phosphorylation level of AMPK, LC3-II/LC3-I ratio, ROS level and apoptosis rate were significantly reduced in Compound C group (P<0.05). Compared with Compound C group, the phosphorylation level of AMPK, LC3-II/LC3-I ratio, ROS level and apoptosis rate were significantly increased in Compound C+salanolic acid B 10 μg/mL group (P<0.05). Conclusion Salvianolic acid B promotes oxidative stressinduced apoptosis and autophagy of thyroid cancer cells through AMPK activation.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-09-22
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司